Skip to main content
31 March 2025
Last updated:
Sunday 30 March 2025
User account anon menu
Login
Register and subscribe
Search
Home
News
News
Appointments
Events
About MedNous
Who We Are
Editorial Board
Editorial Policy
Research Directory
Research Directory
Organisations
Interviewees
Terms
Topics
Contact Us
Contact Form
Menu
Breadcrumb
Home
Research Directory
Research Directory
New oncology drugs in pre-registration, late stage development
Read more
FDA guidance on drugs for early Alzheimer's disease
Read more
Breakthroughs for European bipharma over the horizon
Read more
Treating hearing loss as people age
Read more
European Biopharma R&D in 2023
Read more
EMA reflects on 2023
Read more
Oncology Review: New drugs for myeloma, breast cancer reached the market in 2023
Read more
EMA adopts AI workplan
Read more
EMA launches consultation on AI
Read more
ESMO: New drug combinations show promise for cancer
Read more
Pagination
First page
« First
Previous page
‹‹
Page
1
Page
2
Current page
3
Page
4
Page
5
Page
6
Page
7
Page
8
Page
9
…
Next page
››
Last page
Last »
Home
News
News
Appointments
Events
About MedNous
Who We Are
Editorial Board
Editorial Policy
Research Directory
Research Directory
Organisations
Interviewees
Terms
Topics
Contact Us
Contact Form
